ReP USP - Resultado da busca

Artigo de periodico
Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein (2024)
Silva, Mariângela de Oliveira ; Castro-Amarante, Maria Fernanda ; Carvalho, Alexia Adrianne Venceslau Brito ; Almeida, Bianca da Silva; Daher, Isabela Pazotti ; Souza-Silva, Guilherme Antonio de ; Yamamoto, Marcio Massao ; Koike, Gabriela ; Souza, Edmarcia Elisa de ; Wrenger, Carsten ; Ferreira, Luis Carlos de Souza ; Boscardin, Silvia Beatriz
Source: Vaccines. Unidades: ICB, FM
Subjects: PARASITOLOGIA, MICROBIOLOGIA, PROTEÍNAS RECOMBINANTES, PROTEÍNAS SANGUÍNEAS, ANTICORPOS, IMUNOGENICIDADE DA VACINA, IMUNOGENÉTICA, IMUNOGLOBULINAS, COVID-19, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Mariângela de Oliveira et al. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, v. 12, n. 4, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/vaccines12040356. Acesso em: 02 nov. 2024.
APA
Silva, M. de O., Castro-Amarante, M. F., Carvalho, A. A. V. B., Almeida, B. da S., Daher, I. P., Souza-Silva, G. A. de, et al. (2024). Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein. Vaccines, 12( 4), 14 . doi:10.3390/vaccines12040356
NLM
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/vaccines12040356
Vancouver
Silva M de O, Castro-Amarante MF, Carvalho AAVB, Almeida B da S, Daher IP, Souza-Silva GA de, Yamamoto MM, Koike G, Souza EE de, Wrenger C, Ferreira LC de S, Boscardin SB. Enhanced immunogenicity and protective effects against SARS-CoV-2 following immunization with a recombinant RBD-IgG chimeric protein [Internet]. Vaccines. 2024 ; 12( 4): 14 .[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/vaccines12040356
Artigo de periodico
Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape (2023)
Oliveira, Jamille Ramos ; Ruiz, Cesar Manuel Remuzgo ; Machado, Rafael Rahal Guaragna ; Urbanski, Alysson Henrique ; Magawa, Jhosiene Yukari; Daher, Isabela Pazotti; Urbanski, Alysson Henrique ; Schmitz, Gabriela Justamante Händel ; Arcuri, Helen Andrade; Ferreira, Marcelo Alves ; Sasahara, Greyce Luri ; Medeiros, Giuliana Xavier de ; Silva Júnior, Roberto Carlos Vieira da ; Rosa, Daniela Santoro ; Nakaya, Helder Takashi Imoto ; Gadermaier, Gabriele; Coelho, Verônica ; Santos, Keity Souza ; Durigon, Edison Luiz ; Boscardin, Silvia Beatriz ; Schechtman, Deborah ; Cunha Neto, Edecio; Kalil Filho, Jorge Elias ; Coelho, Veronica Porto Carreiro de Vasconcellos
Source: Frontiers in Immunology. Unidades: ICB, IQ, FM, FCF
Subjects: MICROBIOLOGIA, PARASITOLOGIA, ANTICORPOS, COVID-19, VACINAS VIRAIS, EPITOPOS, IMUNOGLOBULINAS, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA, PEPTÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Jamille Ramos et al. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape. Frontiers in Immunology, v. 13, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.1010105. Acesso em: 02 nov. 2024.
APA
Oliveira, J. R., Ruiz, C. M. R., Machado, R. R. G., Urbanski, A. H., Magawa, J. Y., Daher, I. P., et al. (2023). Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape. Frontiers in Immunology, 13, 1-15. doi:10.3389/fimmu.2022.1010105
NLM
Oliveira JR, Ruiz CMR, Machado RRG, Urbanski AH, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Arcuri HA, Ferreira MA, Sasahara GL, Medeiros GX de, Silva Júnior RCV da, Rosa DS, Nakaya HTI, Gadermaier G, Coelho V, Santos KS, Durigon EL, Boscardin SB, Schechtman D, Cunha Neto E, Kalil Filho JE, Coelho VPC de V. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape [Internet]. Frontiers in Immunology. 2023 ; 13 1-15.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fimmu.2022.1010105
Vancouver
Oliveira JR, Ruiz CMR, Machado RRG, Urbanski AH, Magawa JY, Daher IP, Urbanski AH, Schmitz GJH, Arcuri HA, Ferreira MA, Sasahara GL, Medeiros GX de, Silva Júnior RCV da, Rosa DS, Nakaya HTI, Gadermaier G, Coelho V, Santos KS, Durigon EL, Boscardin SB, Schechtman D, Cunha Neto E, Kalil Filho JE, Coelho VPC de V. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape [Internet]. Frontiers in Immunology. 2023 ; 13 1-15.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fimmu.2022.1010105
Artigo de periodico
Heterologous DNA prime- subunit protein boost with Chikungunya virus E2 induces neutralizing antibodies and cellular-mediated immunity (2023)
Coirada, Fernanda Caroline ; Fernandes, Edgar Ruz ; Mello, Lucas Rodrigues de ; Schuch, Viviane ; Campos, Gúbio Soares ; Carla Torres Braconi ; Rosa, Daniela Santoro ; Boscardin, Silvia Beatriz
Source: International Journal of Molecular Sciences. Unidades: ICB, FCF
Subjects: PARASITOLOGIA, ANTICORPOS, LINFÓCITOS T, IMUNOLOGIA CELULAR, VÍRUS CHIKUNGUNYA, VACINAS VIRAIS, PROTEÍNAS RECOMBINANTES, ADJUVANTES IMUNOLÓGICOS, GLICOPROTEÍNAS, IMUNOGENICIDADE DA VACINA, CAMUNDONGOS, CÉLULAS DENDRÍTICAS, EPITOPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COIRADA, Fernanda Caroline et al. Heterologous DNA prime- subunit protein boost with Chikungunya virus E2 induces neutralizing antibodies and cellular-mediated immunity. International Journal of Molecular Sciences, v. 24, p. 1-22, 2023Tradução . . Disponível em: https://doi.org/10.3390/ijms241310517. Acesso em: 02 nov. 2024.
APA
Coirada, F. C., Fernandes, E. R., Mello, L. R. de, Schuch, V., Campos, G. S., Carla Torres Braconi,, et al. (2023). Heterologous DNA prime- subunit protein boost with Chikungunya virus E2 induces neutralizing antibodies and cellular-mediated immunity. International Journal of Molecular Sciences, 24, 1-22. doi:10.3390/ijms241310517
NLM
Coirada FC, Fernandes ER, Mello LR de, Schuch V, Campos GS, Carla Torres Braconi, Rosa DS, Boscardin SB. Heterologous DNA prime- subunit protein boost with Chikungunya virus E2 induces neutralizing antibodies and cellular-mediated immunity [Internet]. International Journal of Molecular Sciences. 2023 ; 24 1-22.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/ijms241310517
Vancouver
Coirada FC, Fernandes ER, Mello LR de, Schuch V, Campos GS, Carla Torres Braconi, Rosa DS, Boscardin SB. Heterologous DNA prime- subunit protein boost with Chikungunya virus E2 induces neutralizing antibodies and cellular-mediated immunity [Internet]. International Journal of Molecular Sciences. 2023 ; 24 1-22.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/ijms241310517
Artigo de periodico
Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes (2023)
Fotoran, Wesley L. ; Silva, Jamile Ramos da ; Glitz, Christiane ; Ferreira, Luís Carlos de Souza ; Wunderlich, Gerhard
Source: Pharmaceutics. Unidade: ICB
Subjects: MICROBILOGIA, PARASITOLOGIA, REPLICAÇÃO DO DNA, REPLICAÇÃO VIRAL, VACINAS VIRAIS, LIPOSSOMOS, ÁCIDOS NUCLEICOS, RNA MENSAGEIRO, COVID-19, NUCLEOSÍDEOS, MICRORNAS, MALÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FOTORAN, Wesley L. et al. Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes. Pharmaceutics, v. 15, n. 4, p. 1-17, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15041223. Acesso em: 02 nov. 2024.
APA
Fotoran, W. L., Silva, J. R. da, Glitz, C., Ferreira, L. C. de S., & Wunderlich, G. (2023). Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes. Pharmaceutics, 15( 4), 1-17. doi:10.3390/pharmaceutics15041223
NLM
Fotoran WL, Silva JR da, Glitz C, Ferreira LC de S, Wunderlich G. Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-17.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/pharmaceutics15041223
Vancouver
Fotoran WL, Silva JR da, Glitz C, Ferreira LC de S, Wunderlich G. Establishment of an antiplasmodial vaccine based on PfRH5-Encoding RNA replicons stabilized by cationic liposomes [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-17.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/pharmaceutics15041223
Artigo de periodico
Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells (2023)
Lunardelli, Victória Alves Santos ; Almeida, Bianca da Silva ; Apostolico, Juliana de Souza ; Rezende, Thais; Yamamoto, Marcio Massao ; Pereira, Samuel Santos ; Bueno, Maria Fernanda Campagnari ; Pereira, Lennon Ramos ; Karina Inacio Carvalho ; Slhessarenko, Renata Dezengrini ; Rosa, Daniela Santoro ; Ferreira, Luís Carlos de Souza ; Boscardin, Silvia Beatriz
Source: Frontiers in Immunology. Unidade: ICB
Subjects: MICROBIOLOGIA, PARASITOLOGIA, ZIKA VÍRUS, ZIKA VÍRUS, CAMUNDONGOS ENDOGÂMICOS C57BL, DROSOPHILA, VACINAS VIRAIS, INFECÇÕES POR VÍRUS DE RNA, PROTEÍNAS RECOMBINANTES, GLICOPROTEÍNAS, CÁPSULAS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUNARDELLI, Victória Alves Santos et al. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells. Frontiers in Immunology, v. 14, p. 1-14, 2023Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2023.1071041. Acesso em: 02 nov. 2024.
APA
Lunardelli, V. A. S., Almeida, B. da S., Apostolico, J. de S., Rezende, T., Yamamoto, M. M., Pereira, S. S., et al. (2023). Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells. Frontiers in Immunology, 14, 1-14. doi:10.3389/fimmu.2023.1071041
NLM
Lunardelli VAS, Almeida B da S, Apostolico J de S, Rezende T, Yamamoto MM, Pereira SS, Bueno MFC, Pereira LR, Karina Inacio Carvalho, Slhessarenko RD, Rosa DS, Ferreira LC de S, Boscardin SB. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells [Internet]. Frontiers in Immunology. 2023 ; 14 1-14.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fimmu.2023.1071041
Vancouver
Lunardelli VAS, Almeida B da S, Apostolico J de S, Rezende T, Yamamoto MM, Pereira SS, Bueno MFC, Pereira LR, Karina Inacio Carvalho, Slhessarenko RD, Rosa DS, Ferreira LC de S, Boscardin SB. Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells [Internet]. Frontiers in Immunology. 2023 ; 14 1-14.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fimmu.2023.1071041
Artigo de periodico
ZnO-Based electrochemical immunosensor to assess vaccine-induced antibody-mediated immunity against Wild-Type and Gamma SARS-CoV-2 strains (2023)
Nunez, Freddy A. ; Castro, Ana C. H. ; Daher, Isabela P. ; Cunha Neto, Edecio ; Kalil, Jorge ; Boscardin, Silvia Beatriz ; Lanfredi, Alexandre J. C. ; Oliveira, Vivian L. de ; Alves, Wendel A.
Source: Biosensors. Unidades: FM, ICB
Subjects: PARASITOLOGIA, ANTICORPOS, VACINAS VIRAIS, COVID-19, IMUNIDADE, TESTES SOROLÓGICOS, SOROS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NUNEZ, Freddy A. et al. ZnO-Based electrochemical immunosensor to assess vaccine-induced antibody-mediated immunity against Wild-Type and Gamma SARS-CoV-2 strains. Biosensors, v. 13, n. 3, p. 1-14, 2023Tradução . . Disponível em: https://doi.org/10.3390/bios13030371. Acesso em: 02 nov. 2024.
APA
Nunez, F. A., Castro, A. C. H., Daher, I. P., Cunha Neto, E., Kalil, J., Boscardin, S. B., et al. (2023). ZnO-Based electrochemical immunosensor to assess vaccine-induced antibody-mediated immunity against Wild-Type and Gamma SARS-CoV-2 strains. Biosensors, 13( 3), 1-14. doi:10.3390/bios13030371
NLM
Nunez FA, Castro ACH, Daher IP, Cunha Neto E, Kalil J, Boscardin SB, Lanfredi AJC, Oliveira VL de, Alves WA. ZnO-Based electrochemical immunosensor to assess vaccine-induced antibody-mediated immunity against Wild-Type and Gamma SARS-CoV-2 strains [Internet]. Biosensors. 2023 ; 13( 3): 1-14.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/bios13030371
Vancouver
Nunez FA, Castro ACH, Daher IP, Cunha Neto E, Kalil J, Boscardin SB, Lanfredi AJC, Oliveira VL de, Alves WA. ZnO-Based electrochemical immunosensor to assess vaccine-induced antibody-mediated immunity against Wild-Type and Gamma SARS-CoV-2 strains [Internet]. Biosensors. 2023 ; 13( 3): 1-14.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/bios13030371
Artigo de periodico-carta/editorial
Protection against COVID-19: beyond antibodies (2022)
Lacerda, Marcus Vinícius Guimarães ; Bargieri, Daniel Youssef
Source: The Lancet Infectious Diseases. Unidade: ICB
Subjects: PARASITOLOGIA, COVID-19, VÍRUS DE RNA, RNA VIRAL, INFECÇÕES POR CORONAVIRUS, VACINAS VIRAIS, ANTICORPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LACERDA, Marcus Vinícius Guimarães e BARGIERI, Daniel Youssef. Protection against COVID-19: beyond antibodies. The Lancet Infectious Diseases. London: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S1473-3099(21)00561-2. Acesso em: 02 nov. 2024. , 2022
APA
Lacerda, M. V. G., & Bargieri, D. Y. (2022). Protection against COVID-19: beyond antibodies. The Lancet Infectious Diseases. London: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1016/S1473-3099(21)00561-2
NLM
Lacerda MVG, Bargieri DY. Protection against COVID-19: beyond antibodies [Internet]. The Lancet Infectious Diseases. 2022 ; 22( 1): 4-5.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(21)00561-2
Vancouver
Lacerda MVG, Bargieri DY. Protection against COVID-19: beyond antibodies [Internet]. The Lancet Infectious Diseases. 2022 ; 22( 1): 4-5.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/S1473-3099(21)00561-2
Artigo de periodico
Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation (2022)
Jesus, Monica Josiane Rodrigues de ; Favaro, Marianna Teixeira de Pinho ; Carvalho, Aléxia Adrianne Venceslau Brito ; Amarante, Maria Fernanda de Castro ; Almeida, Bianca da Silva ; Silva, Mariângela de Oliveira ; Santos, Robert Andreata ; Barbosa, Cecilia Gomes; Brito, Samantha Carvalho Maia; Freitas Junior, Lucio Holanda Gondim de ; Boscardin, Silvia Beatriz ; Ferreira, Luís Carlos de Souza
Source: Nanomedicine: Nanotechnology, Biology and Medicine. Unidades: BIOTECNOLOGIA, ICB
Subjects: PARASITOLOGIA, MICROBIOLOGIA, VACINAS VIRAIS, IMUNOGLOBULINAS, CORONAVIRUS, COVID-19, LIPOPROTEÍNAS, NANOPARTÍCULAS, CAMUNDONGOS, IMUNOGENICIDADE DA VACINA, DOENÇAS RESPIRATÓRIAS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, Monica Josiane Rodrigues de et al. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation. Nanomedicine: Nanotechnology, Biology and Medicine, v. 45, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2022.102595. Acesso em: 02 nov. 2024.
APA
Jesus, M. J. R. de, Favaro, M. T. de P., Carvalho, A. A. V. B., Amarante, M. F. de C., Almeida, B. da S., Silva, M. de O., et al. (2022). Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation. Nanomedicine: Nanotechnology, Biology and Medicine, 45, 1-11. doi:10.1016/j.nano.2022.102595
NLM
Jesus MJR de, Favaro MT de P, Carvalho AAVB, Amarante MF de C, Almeida B da S, Silva M de O, Santos RA, Barbosa CG, Brito SCM, Freitas Junior LHG de, Boscardin SB, Ferreira LC de S. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2022 ; 45 1-11.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.nano.2022.102595
Vancouver
Jesus MJR de, Favaro MT de P, Carvalho AAVB, Amarante MF de C, Almeida B da S, Silva M de O, Santos RA, Barbosa CG, Brito SCM, Freitas Junior LHG de, Boscardin SB, Ferreira LC de S. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2022 ; 45 1-11.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.nano.2022.102595
Artigo de periodico
Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil (2022)
Santos, Robert Andreata ; Machado, Rafael Rahal Guaragna ; Alves, Rúbens Prince dos Santos ; Sales, Natiely Silva ; Soares, Camila Pereira ; Rodrigues, Karine Bitencourt ; Andrade, Juliana Bannwart ; Fock, Ricardo Ambrósio ; Margarido, Paulo Francisco Ramos ; Carvalho, Cristiane Rodrigues Guzzo ; Boscardin, Silvia Beatriz ; Durigon, Edison Luiz ; Ferreira, Luís Carlos de Souza
Source: Frontiers in Cellular and Infection Microbiology. Unidades: HU, ICB, FCF, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, PARASITOLOGIA, COVID-19, TESTES SOROLÓGICOS, TRIAGEM, SERVIÇOS DE SAÚDE, ESTUDOS RETROSPECTIVOS, ANTICORPOS, ELISA, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Robert Andreata et al. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil. Frontiers in Cellular and Infection Microbiology, v. 12, p. 1-8, 2022Tradução . . Disponível em: https://doi.org/10.3389/fcimb.2022.787411. Acesso em: 02 nov. 2024.
APA
Santos, R. A., Machado, R. R. G., Alves, R. P. dos S., Sales, N. S., Soares, C. P., Rodrigues, K. B., et al. (2022). Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil. Frontiers in Cellular and Infection Microbiology, 12, 1-8. doi:10.3389/fcimb.2022.787411
NLM
Santos RA, Machado RRG, Alves RP dos S, Sales NS, Soares CP, Rodrigues KB, Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LC de S. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-8.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fcimb.2022.787411
Vancouver
Santos RA, Machado RRG, Alves RP dos S, Sales NS, Soares CP, Rodrigues KB, Andrade JB, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LC de S. Validation of serological methods for COVID-19 and retrospective screening of health employees and visitors to the São Paulo University Hospital, Brazil [Internet]. Frontiers in Cellular and Infection Microbiology. 2022 ; 12 1-8.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fcimb.2022.787411
Artigo de periodico
Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon (2021)
Gomes, Laura Cordeiro ; Sanson, Marina Cordeiro Gomes ; Brainin, Philip ; Melo, Maria da Conceição Vieira de; Souza, Rodrigo Medeiros de ; Mazaro, Janaína; Lima, Karine Oliveira; Resende, Júnia Silva; Vieira, Isabelle Victória Martins; Mesquita, Edinilson da Silva; Matos, Luan Oliveira; Dutra, Isabelle Caroline Silva; Palmisano, Giuseppe ; Wrenger, Carsten ; Marinho, Claudio Romero Farias ; Silva, Rita do Socorro Uchôa da
Source: PLOS One. Unidade: ICB
Subjects: PARASITOLOGIA, HEPATITE B, CRIANÇAS, VÍRUS DA HEPATITE B, ORTHOHEPADNAVIRUS, VACINAS VIRAIS, PROGRAMAS DE VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Laura Cordeiro et al. Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon. PLOS One, v. 16, n. 7, p. 1-13, 2021Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0253752. Acesso em: 02 nov. 2024.
APA
Gomes, L. C., Sanson, M. C. G., Brainin, P., Melo, M. da C. V. de, Souza, R. M. de, Mazaro, J., et al. (2021). Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon. PLOS One, 16( 7), 1-13. doi:10.1371/journal.pone.0253752
NLM
Gomes LC, Sanson MCG, Brainin P, Melo M da CV de, Souza RM de, Mazaro J, Lima KO, Resende JS, Vieira IVM, Mesquita E da S, Matos LO, Dutra ICS, Palmisano G, Wrenger C, Marinho CRF, Silva R do SU da. Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon [Internet]. PLOS One. 2021 ; 16( 7): 1-13.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1371/journal.pone.0253752
Vancouver
Gomes LC, Sanson MCG, Brainin P, Melo M da CV de, Souza RM de, Mazaro J, Lima KO, Resende JS, Vieira IVM, Mesquita E da S, Matos LO, Dutra ICS, Palmisano G, Wrenger C, Marinho CRF, Silva R do SU da. Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon [Internet]. PLOS One. 2021 ; 16( 7): 1-13.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1371/journal.pone.0253752
Artigo de periodico
Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies (2021)
Carvalho, Aléxia Adrianne Venceslau ; Favaro, Marianna Teixeira de Pinho ; Pereira, Lennon Ramos ; Jesus, Mônica Josiane Rodrigues ; Pereira, Samuel Santos ; Santos, Robert Andreata ; Alves, Rúbens Prince dos Santos ; Amarante, Maria Fernanda Castro ; Rodrigues, Karine Bitencourt ; Silva, Jamile Ramos da ; Machado, Rafael Rahal Guaragna ; Cunha, Marielton dos Passos ; Zanotto, Paolo Marinho de Andrade ; Fotoran, Wesley Luzetti ; Wunderlich, Gerhard ; Durigon, Edison Luiz ; Ferreira, Luís Carlos de Souza
Source: Nanomedicine: Nanotechnology, Biology and Medicine. Unidades: ICB, BIOTECNOLOGIA
Subjects: PARASITOLOGIA, MICROBIOLOGIA, VÍRUS CHIKUNGUNYA, PROTEÍNAS RECOMBINANTES, VÍRUS DE RNA, NANOPARTÍCULAS, ANTICORPOS, INFLAMAÇÃO, VACINAS VIRAIS, ADJUVANTES IMUNOLÓGICOS, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Aléxia Adrianne Venceslau et al. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies. Nanomedicine: Nanotechnology, Biology and Medicine, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2021.102445. Acesso em: 02 nov. 2024.
APA
Carvalho, A. A. V., Favaro, M. T. de P., Pereira, L. R., Jesus, M. J. R., Pereira, S. S., Santos, R. A., et al. (2021). Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies. Nanomedicine: Nanotechnology, Biology and Medicine. doi:10.1016/j.nano.2021.102445
NLM
Carvalho AAV, Favaro MT de P, Pereira LR, Jesus MJR, Pereira SS, Santos RA, Alves RP dos S, Amarante MFC, Rodrigues KB, Silva JR da, Machado RRG, Cunha M dos P, Zanotto PM de A, Fotoran WL, Wunderlich G, Durigon EL, Ferreira LC de S. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2021 ;[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.nano.2021.102445
Vancouver
Carvalho AAV, Favaro MT de P, Pereira LR, Jesus MJR, Pereira SS, Santos RA, Alves RP dos S, Amarante MFC, Rodrigues KB, Silva JR da, Machado RRG, Cunha M dos P, Zanotto PM de A, Fotoran WL, Wunderlich G, Durigon EL, Ferreira LC de S. Nano-multilamellar lipid vesicles loaded with a recombinant form of the chikungunya virus E2 protein improve the induction of virus-neutralizing antibodies [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2021 ;[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.nano.2021.102445
Artigo de periodico
Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites (2021)
Silva, Mariângela de Oliveira; Almeida, Bianca da Silva ; Sales, Natiely Silva ; Diniz, Mariana de Oliveira; Aps, Luana Raposo de Melo Morais ; Rodrigues, Karine Bitencourt ; Silva, Jamile Ramos da ; Moreno, Ana Caroline Rippi ; Ribeiro, Bruna Felício Milazzotto Maldonado Porchia ; Sulczewski, Fernando Bandeira ; Boscardin, Silvia Beatriz ; Ferreira, Luís Carlos de Souza
Source: International Journal of Biological Sciences. Unidades: ICB, BIOTECNOLOGIA
Subjects: MICROBIOLOGUA, PARASITOLOGIA, CÉLULAS DENDRÍTICAS, HPV, IMUNOTERAPIA, CÉLULAS CULTIVADAS DE TUMOR, ONCOPROTEÍNAS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, VACINAS VIRAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Mariângela de Oliveira et al. Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites. International Journal of Biological Sciences, v. 17, n. 11, p. 2944-2956, 2021Tradução . . Disponível em: https://doi.org/10.7150/ijbs.57038. Acesso em: 02 nov. 2024.
APA
Silva, M. de O., Almeida, B. da S., Sales, N. S., Diniz, M. de O., Aps, L. R. de M. M., Rodrigues, K. B., et al. (2021). Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites. International Journal of Biological Sciences, 17( 11), 2944-2956. doi:10.7150/ijbs.57038
NLM
Silva M de O, Almeida B da S, Sales NS, Diniz M de O, Aps LR de MM, Rodrigues KB, Silva JR da, Moreno ACR, Ribeiro BFMMP, Sulczewski FB, Boscardin SB, Ferreira LC de S. Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites [Internet]. International Journal of Biological Sciences. 2021 ; 17( 11): 2944-2956.[citado 2024 nov. 02 ] Available from: https://doi.org/10.7150/ijbs.57038
Vancouver
Silva M de O, Almeida B da S, Sales NS, Diniz M de O, Aps LR de MM, Rodrigues KB, Silva JR da, Moreno ACR, Ribeiro BFMMP, Sulczewski FB, Boscardin SB, Ferreira LC de S. Antigen delivery to DEC205+ dendritic cells induces immunological memory and protective therapeutic effects against HPV-associated tumors at different anatomical sites [Internet]. International Journal of Biological Sciences. 2021 ; 17( 11): 2944-2956.[citado 2024 nov. 02 ] Available from: https://doi.org/10.7150/ijbs.57038
Artigo de periodico
Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses (2020)
Amaral, Marcelo Pires ; Apostolico, Juliana de Souza ; Tomita, Nádia ; Coirada, Fernanda Caroline ; Lunardelli, Victória Alves Santos; Fernandes, Edgar Ruz ; Souza, Higo Fernando Santos ; Astray, Renato Mancini ; Boscardin, Silvia Beatriz ; Rosa, Daniela Santoro
Source: Vaccine. Unidade: ICB
Subjects: PARASITOLOGIA, ZIKA VÍRUS, ADJUVANTES IMUNOLÓGICOS, VACINAS VIRAIS, GLICOPROTEÍNAS, PROTEÍNAS DA MEMBRANA, CAMUNDONGOS, DNA RECOMBINANTE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Marcelo Pires et al. Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses. Vaccine, v. 38, n. 20, p. 3653-3664, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2020.03.037. Acesso em: 02 nov. 2024.
APA
Amaral, M. P., Apostolico, J. de S., Tomita, N., Coirada, F. C., Lunardelli, V. A. S., Fernandes, E. R., et al. (2020). Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses. Vaccine, 38( 20), 3653-3664. doi:10.1016/j.vaccine.2020.03.037
NLM
Amaral MP, Apostolico J de S, Tomita N, Coirada FC, Lunardelli VAS, Fernandes ER, Souza HFS, Astray RM, Boscardin SB, Rosa DS. Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses [Internet]. Vaccine. 2020 ; 38( 20): 3653-3664.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2020.03.037
Vancouver
Amaral MP, Apostolico J de S, Tomita N, Coirada FC, Lunardelli VAS, Fernandes ER, Souza HFS, Astray RM, Boscardin SB, Rosa DS. Homologous prime-boost with Zika virus envelope protein and poly (I:C) induces robust specific humoral and cellular immune responses [Internet]. Vaccine. 2020 ; 38( 20): 3653-3664.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.vaccine.2020.03.037
Artigo de periodico
Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 (2020)
Pereira, Lennon Ramos ; Vicentin, Elaine Cristina Matos; Pereira, Sara Araujo ; Maeda, Denicar Lina Nascimento Fabris; Alves, Rubens Prince dos Santos ; Santos, Robert Andreata ; Sousa, Francielle Tramontini Gomes de ; Yamamoto, Marcio Massao ; Amarante, Maria Fernanda Castro ; Favaro, Marianna Teixeira de Pinho ; Romano, Camila Malta ; Sabino, Ester Cerdeira ; Boscardin, Silvia Beatriz ; Ferreira, Luís Carlos de Souza
Source: Vaccines. Unidades: ICB, FM
Subjects: PARASITOLOGIA, MICROBIOLOGIA, VÍRUS DA DENGUE, CÉLULAS DENDRÍTICAS, ANTICORPOS MONOCLONAIS, IMUNOGENÉTICA, IMUNOGENICIDADE DA VACINA, VACINAS VIRAIS, FLAVIVIRUS, VÍRUS DE RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Lennon Ramos et al. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1. Vaccines, v. 8, p. 19 , 2020Tradução . . Disponível em: https://doi.org/10.3390/vaccines8040565. Acesso em: 02 nov. 2024.
APA
Pereira, L. R., Vicentin, E. C. M., Pereira, S. A., Maeda, D. L. N. F., Alves, R. P. dos S., Santos, R. A., et al. (2020). Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1. Vaccines, 8, 19 . doi:10.3390/vaccines8040565
NLM
Pereira LR, Vicentin ECM, Pereira SA, Maeda DLNF, Alves RP dos S, Santos RA, Sousa FTG de, Yamamoto MM, Amarante MFC, Favaro MT de P, Romano CM, Sabino EC, Boscardin SB, Ferreira LC de S. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 [Internet]. Vaccines. 2020 ; 8 19 .[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/vaccines8040565
Vancouver
Pereira LR, Vicentin ECM, Pereira SA, Maeda DLNF, Alves RP dos S, Santos RA, Sousa FTG de, Yamamoto MM, Amarante MFC, Favaro MT de P, Romano CM, Sabino EC, Boscardin SB, Ferreira LC de S. Intradermal delivery of dendritic cell-targeting chimeric mAbs genetically fused to type 2 Dengue virus nonstructural protein 1 [Internet]. Vaccines. 2020 ; 8 19 .[citado 2024 nov. 02 ] Available from: https://doi.org/10.3390/vaccines8040565
Artigo de periodico
Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy (2020)
Tzelepis, Fanny ; Birdi, Harsimrat Kaur ; Jirovec, Anna ; Boscardin, Silvia Beatriz ; Souza, Christiano Tanese de; Hooshyar, Mohsen; Chen, Andrew; Sutherland, Keara; Parks, Robin J.; Werier, Joel; Diallo, Jean-Simon
Source: Molecular Therapy - Oncolytics. Unidade: ICB
Subjects: PARASITOLOGIA, IMUNOTERAPIA, VACINAS VIRAIS, RHABDOVIRIDAE, VÍRUS DE RNA, NEOPLASIAS, VETORES, ANTÍGENOS DE VÍRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TZELEPIS, Fanny et al. Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy. Molecular Therapy - Oncolytics, v. 19, p. 240-252, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.omto.2020.10.007. Acesso em: 02 nov. 2024.
APA
Tzelepis, F., Birdi, H. K., Jirovec, A., Boscardin, S. B., Souza, C. T. de, Hooshyar, M., et al. (2020). Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy. Molecular Therapy - Oncolytics, 19, 240-252. doi:10.1016/j.omto.2020.10.007
NLM
Tzelepis F, Birdi HK, Jirovec A, Boscardin SB, Souza CT de, Hooshyar M, Chen A, Sutherland K, Parks RJ, Werier J, Diallo J-S. Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy [Internet]. Molecular Therapy - Oncolytics. 2020 ; 19 240-252.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.omto.2020.10.007
Vancouver
Tzelepis F, Birdi HK, Jirovec A, Boscardin SB, Souza CT de, Hooshyar M, Chen A, Sutherland K, Parks RJ, Werier J, Diallo J-S. Oncolytic rhabdovirus vaccine boosts chimeric Anti-DEC205 priming for effective cancer immunotherapy [Internet]. Molecular Therapy - Oncolytics. 2020 ; 19 240-252.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1016/j.omto.2020.10.007
Artigo de periodico
São Paulo School of Advanced Sciences on Vaccines: an overview (2020)
Sorgi, Sara ; Bonezi, Vivian; Dominguez, Mariana Ribeiro ; Gimenez, Alba Marina; Dobrescu, Irina ; Boscardin, Silvia Beatriz ; Nakaya, Helder Takashi Imoto ; Bargieri, Daniel Youssef ; Soares, Irene da Silva ; Silveira, Eduardo Lani Volpe da
Source: Journal of Venomous Animals and Toxins Including Tropical Diseases. Unidades: ICB, FCF
Subjects: PARASITOLOGIA, VACINAS, ANTÍGENOS, VACINAS VIRAIS, IMUNIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SORGI, Sara et al. São Paulo School of Advanced Sciences on Vaccines: an overview. Journal of Venomous Animals and Toxins Including Tropical Diseases, v. 26, p. 14 , 2020Tradução . . Disponível em: https://doi.org/10.1590/1678-9199-JVATITD-2019-0061. Acesso em: 02 nov. 2024.
APA
Sorgi, S., Bonezi, V., Dominguez, M. R., Gimenez, A. M., Dobrescu, I., Boscardin, S. B., et al. (2020). São Paulo School of Advanced Sciences on Vaccines: an overview. Journal of Venomous Animals and Toxins Including Tropical Diseases, 26, 14 . doi:10.1590/1678-9199-JVATITD-2019-0061
NLM
Sorgi S, Bonezi V, Dominguez MR, Gimenez AM, Dobrescu I, Boscardin SB, Nakaya HTI, Bargieri DY, Soares I da S, Silveira ELV da. São Paulo School of Advanced Sciences on Vaccines: an overview [Internet]. Journal of Venomous Animals and Toxins Including Tropical Diseases. 2020 ; 26 14 .[citado 2024 nov. 02 ] Available from: https://doi.org/10.1590/1678-9199-JVATITD-2019-0061
Vancouver
Sorgi S, Bonezi V, Dominguez MR, Gimenez AM, Dobrescu I, Boscardin SB, Nakaya HTI, Bargieri DY, Soares I da S, Silveira ELV da. São Paulo School of Advanced Sciences on Vaccines: an overview [Internet]. Journal of Venomous Animals and Toxins Including Tropical Diseases. 2020 ; 26 14 .[citado 2024 nov. 02 ] Available from: https://doi.org/10.1590/1678-9199-JVATITD-2019-0061
Artigo de jornal
Quantas vidas vale um clique? (2020)
Bargieri, Daniel Youssef ; Nakaya, Helder Takashi Imoto
Source: Jornal da USP. Unidades: ICB, FCF
Subjects: INFORMAÇÃO EM SAÚDE, VACINAS VIRAIS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARGIERI, Daniel Youssef e NAKAYA, Helder Takashi Imoto. Quantas vidas vale um clique?. Tradução . Jornal da USP, São Paulo, 2020. Disponível em: https://jornal.usp.br/artigos/quantas-vidas-vale-um-clique. Acesso em: 02 nov. 2024.
APA
Bargieri, D. Y., & Nakaya, H. T. I. (2020). Quantas vidas vale um clique? Jornal da USP. São Paulo: Instituto de Ciências Biomédicas, Universidade de São Paulo. Recuperado de https://jornal.usp.br/artigos/quantas-vidas-vale-um-clique
NLM
Bargieri DY, Nakaya HTI. Quantas vidas vale um clique? [Internet]. Jornal da USP. 2020 ;[citado 2024 nov. 02 ] Available from: https://jornal.usp.br/artigos/quantas-vidas-vale-um-clique
Vancouver
Bargieri DY, Nakaya HTI. Quantas vidas vale um clique? [Internet]. Jornal da USP. 2020 ;[citado 2024 nov. 02 ] Available from: https://jornal.usp.br/artigos/quantas-vidas-vale-um-clique
Artigo de periodico
Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III (2019)
Zaneti, Arthur Baruel; Yamamoto, Marcio Massao ; Sulczewski, Fernando Bandeira; Almeida, Bianca da Silva; Souza, Higo Fernando Santos ; Ferreira, Natália Soares; Maeda, Denicar Lina Nascimento Fabris; Sales, Natiely Silva; Rosa, Daniela Santoro; Ferreira, Luís Carlos de Souza ; Boscardin, Silvia Beatriz
Source: Frontiers in Immunology. Unidade: ICB
Subjects: PARASITOLOGIA, MICROBIOLOGIA, CÉLULAS DENDRÍTICAS, VACINAS VIRAIS, DNA VIRAL, DENGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETI, Arthur Baruel et al. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III. Frontiers in Immunology, v. 10, p. 1-15, 2019Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.00059. Acesso em: 02 nov. 2024.
APA
Zaneti, A. B., Yamamoto, M. M., Sulczewski, F. B., Almeida, B. da S., Souza, H. F. S., Ferreira, N. S., et al. (2019). Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III. Frontiers in Immunology, 10, 1-15. doi:10.3389/fimmu.2019.00059
NLM
Zaneti AB, Yamamoto MM, Sulczewski FB, Almeida B da S, Souza HFS, Ferreira NS, Maeda DLNF, Sales NS, Rosa DS, Ferreira LC de S, Boscardin SB. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III [Internet]. Frontiers in Immunology. 2019 ; 10 1-15.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fimmu.2019.00059
Vancouver
Zaneti AB, Yamamoto MM, Sulczewski FB, Almeida B da S, Souza HFS, Ferreira NS, Maeda DLNF, Sales NS, Rosa DS, Ferreira LC de S, Boscardin SB. Dendritic cell targeting using a DNA vaccine induces specific antibodies and CD4+ T cells to the dengue virus envelope protein Domain III [Internet]. Frontiers in Immunology. 2019 ; 10 1-15.[citado 2024 nov. 02 ] Available from: https://doi.org/10.3389/fimmu.2019.00059
Trabalho de evento-resumo periodico
A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses (2018)
Baruel Zaneti, A. ; Massao Yamamoto, Marcio ; Bandeira Sulczewski, F. ; da Silva Almeida, B.; Santos Souza, H. F.; Silva Sale , N.; Ferreira, Luís Carlos de Souza ; Boscardin, Silvia Beatriz
Source: European Journal of Immunology. Conference titles: International Symposium on Dentritic Cells. Unidade: ICB
Subjects: PARASITOLOGIA, VACINAS VIRAIS, DENGUE, CÉLULAS DENDRÍTICAS, IMUNOLOGIA CELULAR, PROTEÍNAS, DNA VIRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARUEL ZANETI, A. et al. A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses. European Journal of Immunology. Weinheim: Wiley - V C H Verlag GmbH & Co. KGaA. Disponível em: https://doi.org/10.1002/eji.201871000. Acesso em: 02 nov. 2024. , 2018
APA
Baruel Zaneti, A., Massao Yamamoto, M., Bandeira Sulczewski, F., da Silva Almeida, B., Santos Souza, H. F., Silva Sale , N., et al. (2018). A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses. European Journal of Immunology. Weinheim: Wiley - V C H Verlag GmbH & Co. KGaA. doi:10.1002/eji.201871000
NLM
Baruel Zaneti A, Massao Yamamoto M, Bandeira Sulczewski F, da Silva Almeida B, Santos Souza HF, Silva Sale N, Ferreira LC de S, Boscardin SB. A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses [Internet]. European Journal of Immunology. 2018 ; 48 1-193.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1002/eji.201871000
Vancouver
Baruel Zaneti A, Massao Yamamoto M, Bandeira Sulczewski F, da Silva Almeida B, Santos Souza HF, Silva Sale N, Ferreira LC de S, Boscardin SB. A DNA vaccine targeting the dengue virus envelope protein domain III to dendritic cells improves humoral and cellular immune responses [Internet]. European Journal of Immunology. 2018 ; 48 1-193.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1002/eji.201871000
Artigo de periodico
Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors (2017)
Ribeiro, Bruna Felício Milazzotto Maldonado Porchia; Moreno, Ana Carolina Ramos; Ramos, Rodrigo Nalio; Diniz, Mariana de OLiveira; Andrade, Laís Helena Teixeira Merlin de; Rosa, Daniela S.; Barbuto, José Alexandre Marzagão ; Boscardin, Silvia Beatriz ; Ferreira, Luís Carlos de Souza
Source: Molecular Cancer Therapeutics. Unidade: ICB
Subjects: IMUNOLOGIA, MICROBIOLOGIA, PARASITOLOGIA, HERPES SIMPLES, PAPILLOMAVIRUS, VACINAS VIRAIS, NEOPLASIAS DO COLO UTERINO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Bruna Felício Milazzotto Maldonado Porchia et al. Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors. Molecular Cancer Therapeutics, v. 16, n. 9, p. 1922-1933, 2017Tradução . . Disponível em: https://doi.org/10.1158/1535-7163.MCT-17-0071. Acesso em: 02 nov. 2024.
APA
Ribeiro, B. F. M. M. P., Moreno, A. C. R., Ramos, R. N., Diniz, M. de O. L., Andrade, L. H. T. M. de, Rosa, D. S., et al. (2017). Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors. Molecular Cancer Therapeutics, 16( 9), 1922-1933. doi:10.1158/1535-7163.MCT-17-0071
NLM
Ribeiro BFMMP, Moreno ACR, Ramos RN, Diniz M de OL, Andrade LHTM de, Rosa DS, Barbuto JAM, Boscardin SB, Ferreira LC de S. Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors [Internet]. Molecular Cancer Therapeutics. 2017 ; 16( 9): 1922-1933.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1158/1535-7163.MCT-17-0071
Vancouver
Ribeiro BFMMP, Moreno ACR, Ramos RN, Diniz M de OL, Andrade LHTM de, Rosa DS, Barbuto JAM, Boscardin SB, Ferreira LC de S. Herpes simplex virus glycoprotein D targets a specific dendritic cell subset and improves the performance of vaccines to human Papillomavirus-associated tumors [Internet]. Molecular Cancer Therapeutics. 2017 ; 16( 9): 1922-1933.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1158/1535-7163.MCT-17-0071

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration